NeoImmuneTech, Inc. (KOSDAQ:950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,052.00
-23.00 (-2.14%)
Jun 27, 2025, 3:30 PM KST
-36.55%
Market Cap 116.17B
Revenue (ttm) 183.62M
Net Income (ttm) -37.54B
Shares Out 98.87M
EPS (ttm) -379.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 571,409
Average Volume 1,538,682
Open 1,075.00
Previous Close 1,075.00
Day's Range 1,050.00 - 1,080.00
52-Week Range 985.00 - 1,881.00
Beta 0.97
RSI 34.33
Earnings Date Aug 14, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 52
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.